Teva Pharmaceuticals said Monday it agreed to pay $512 million to settle a class-action lawsuit alleging that Cephalon, which was later bought by Teva, delayed the availability of the generic version of the sleep-disorder drug Provigil.
from WSJ.com: US Business http://ift.tt/1DFkgKX
via IFTTT
No comments:
Post a Comment